Qualigen Therapeutics (QLGN) Stock Chart & Stock Price History → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free QLGN Stock Alerts $0.28 0.00 (0.00%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Qualigen Therapeutics Stock Price Performance5 Day Performance-5.85%1 Month Performance-27.17%3 Month Performance-42.35%6 Month Performance-60.08%Year-To-Date Performance-48.47%1 Year Performance-73.14% Receive QLGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. QLGN Stock Chart for Friday, May, 10, 2024 QLGN Chart by TradingView Qualigen Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$0.28$0.28+1.14%$0.29$0.2886,167 shs$1.79 million05/08/2024$0.28$0.28-1.65%$0.30$0.2868,280 shs$1.77 million05/07/2024$0.29$0.28-2.73%$0.30$0.2853,302 shs$1.80 million05/06/2024$0.30$0.29-2.69%$0.32$0.28112,239 shs$1.85 million05/03/2024$0.29$0.30+3.69%$0.33$0.27232,006 shs$1.90 million05/02/2024$0.30$0.29-3.14%$0.29$0.2772,159 shs$1.83 million Get the Latest News and Ratings for QLGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$0.30$0.30-0.03%$0.31$0.2939,825 shs$1.89 million04/30/2024$0.30$0.30+1.63%$0.33$0.2930,190 shs$1.89 million04/29/2024$0.29$0.30+1.55%$0.31$0.2916,316 shs$1.86 million04/26/2024$0.30$0.31+4.34%$0.32$0.299,216 shs$1.96 million04/25/2024$0.31$0.30-3.85%$0.32$0.3017,610 shs$1.87 million04/24/2024$0.32$0.31-1.94%$0.32$0.2924,212 shs$1.95 million04/23/2024$0.30$0.32+6.67%$0.32$0.2914,141 shs$1.99 million04/22/2024$0.32$0.30-7.14%$0.32$0.2946,546 shs$1.86 million04/19/2024$0.31$0.32+2.02%$0.33$0.2929,993 shs$2.01 million04/18/2024$0.30$0.31+4.81%$0.33$0.2927,054 shs$1.97 million04/17/2024$0.30$0.30-0.80%$0.31$0.2847,891 shs$1.88 million04/16/2024$0.32$0.30-6.31%$0.32$0.29186,646 shs$1.89 million04/15/2024$0.33$0.32-3.61%$0.33$0.3136,245 shs$2.02 million04/12/2024$0.37$0.33-9.29%$0.36$0.2961,999 shs$2.09 million04/11/2024$0.39$0.37-5.94%$0.39$0.35236,929 shs$1.90 million04/10/2024$0.40$0.39-2.46%$0.40$0.3743,277 shs$2.02 million04/09/2024$0.38$0.40+4.56%$0.40$0.3883,875 shs$2.07 million04/08/2024$0.40$0.38-3.47%$0.39$0.3739,182 shs$1.98 million04/05/2024$0.39$0.40+2.54%$0.41$0.3664,204 shs$2.05 million04/04/2024$0.42$0.39-8.22%$0.42$0.3825,975 shs$2.00 million04/03/2024$0.40$0.42+4.97%$0.44$0.37148,804 shs$2.18 million04/02/2024$0.39$0.40+1.50%$0.45$0.3988,072 shs$2.07 million04/01/2024$0.40$0.39-1.48%$0.43$0.3919,508 shs$2.04 million03/29/2024$0.40$0.40$0.40$0.3679,811 shs$2.07 million03/28/2024$0.40$0.40-0.99%$0.40$0.3679,611 shs$2.07 million03/27/2024$0.41$0.40-0.49%$0.40$0.3884,022 shs$2.09 million03/26/2024$0.39$0.41+5.45%$0.43$0.37316,659 shs$2.10 million03/25/2024$0.39$0.39-1.03%$0.40$0.3757,981 shs$1.99 million03/22/2024$0.37$0.39+5.76%$0.41$0.3723,208 shs$2.02 million03/21/2024$0.36$0.37+1.94%$0.41$0.3585,846 shs$1.91 million03/20/2024$0.35$0.36+2.01%$0.38$0.3539,190 shs$1.87 million03/19/2024$0.36$0.35-2.02%$0.38$0.3562,348 shs$1.83 million03/18/2024$0.37$0.36-2.49%$0.40$0.3554,429 shs$1.87 million03/15/2024$0.40$0.37-8.37%$0.41$0.34232,755 shs$1.92 millionElon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake.03/14/2024$0.40$0.40+2.28%$0.41$0.3911,750 shs$2.09 million03/13/2024$0.40$0.40-2.45%$0.41$0.3935,282 shs$2.05 million03/12/2024$0.41$0.40-1.24%$0.43$0.4017,558 shs$2.10 million03/11/2024$0.41$0.41+1.23%$0.42$0.3939,259 shs$2.12 million03/08/2024$0.40$0.41+1.25%$0.43$0.4027,799 shs$2.10 million03/07/2024$0.41$0.40-2.44%$0.43$0.4061,508 shs$2.07 million03/06/2024$0.41$0.41$0.43$0.4037,236 shs$2.12 million03/05/2024$0.42$0.41-1.91%$0.42$0.4074,469 shs$2.12 million03/04/2024$0.45$0.42-6.86%$0.46$0.39113,986 shs$2.17 million03/01/2024$0.46$0.45-2.46%$0.48$0.4476,214 shs$2.33 million02/29/2024$0.47$0.46-2.11%$0.48$0.4691,576 shs$2.38 million02/28/2024$0.49$0.47-4.12%$0.51$0.4780,633 shs$2.44 million02/27/2024$0.58$0.49-15.26%$0.58$0.47171,196 shs$2.54 million02/26/2024$0.52$0.58+12.11%$0.59$0.51129,423 shs$3.00 million02/23/2024$0.48$0.52+7.32%$0.54$0.4832,030 shs$2.67 million02/22/2024$0.49$0.48-1.90%$0.52$0.4815,456 shs$2.49 million02/21/2024$0.50$0.49-2.47%$0.50$0.4914,955 shs$2.54 million02/20/2024$0.47$0.50+5.95%$0.51$0.47131,533 shs$2.60 million02/19/2024$0.47$0.47$0.47$0.4721,700 shs$2.46 million02/16/2024$0.47$0.47-0.04%$0.47$0.4711,198 shs$2.46 million02/15/2024$0.47$0.47+0.11%$0.48$0.4618,054 shs$2.46 million02/14/2024$0.47$0.47+1.72%$0.49$0.4628,101 shs$2.46 million02/13/2024$0.46$0.47+0.43%$0.51$0.46120,123 shs$2.41 million02/12/2024$0.49$0.46-5.61%$0.57$0.46303,159 shs$2.40 million02/09/2024$0.51$0.49-3.42%$0.50$0.497,510 shs$2.64 million Related Companies: PRFX Stock Chart BPTH Stock Chart BDRX Stock Chart ATNF Stock Chart GLMD Stock Chart CMND Stock Chart NTBL Stock Chart INM Stock Chart DRMA Stock Chart NBSE Stock Chart Receive QLGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:QLGN) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap Profits[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.